Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS
Combining the TROP2 ADC with Keytruda cut the risk of progression or death by 65% versus Keytruda alone in first-line, PD-L1-positive NSCLC.
Angus Liu
May 21, 2026 5:00pm
In endometrial cancer, Merck and Kelun score with sac-TMT
May 18, 2026 11:21am
Summit shares tumble on interim PD-1/VEGF trial miss
May 1, 2026 10:56am
Shingrix surge, Exdensur flop highlight GSK CEO’s first quarter
Apr 29, 2026 10:47am
Pfizer looks to jump start Elrexfio with topline win
Apr 29, 2026 10:16am
Fierce Biotech
FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm
Apr 28, 2026 2:47pm
